These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 30068867)
1. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling. Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867 [TBL] [Abstract][Full Text] [Related]
2. Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes via PI3K/AKT/GSK3β Signaling Pathway. Zhao Q; Li H; Chang L; Wei C; Yin Y; Bei H; Wang Z; Liang J; Wu Y Biol Pharm Bull; 2019 Aug; 42(8):1310-1321. PubMed ID: 31142701 [TBL] [Abstract][Full Text] [Related]
3. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet. Yang CC; Chen YT; Chen CH; Li YC; Shao PL; Huang TH; Chen YL; Sun CK; Yip HK Biomed Pharmacother; 2019 Aug; 116():108954. PubMed ID: 31108352 [TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats. Wang H; Zhang X; Yu P; Zhou Q; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Che L; Xu J; Bei Y; Li X Int J Med Sci; 2017; 14(5):506-514. PubMed ID: 28539827 [TBL] [Abstract][Full Text] [Related]
6. Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome. Du X; Ma Z; Li L; Zhong X J Cardiovasc Pharmacol; 2021 Sep; 78(5):e675-e680. PubMed ID: 34738551 [TBL] [Abstract][Full Text] [Related]
7. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1. Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401 [TBL] [Abstract][Full Text] [Related]
8. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Lian FZ; Cheng P; Ruan CS; Ling XX; Wang XY; Pan M; Chen ML; Shen AZ; Gao S Biomed Pharmacother; 2019 Sep; 117():109124. PubMed ID: 31228798 [TBL] [Abstract][Full Text] [Related]
9. Effects of butylphthalide on oxidative stress and inflammatory response in rats with myocardial infarction through Akt/Nrf2 signaling pathway. Bai M; Pan CL; Jiang GX; Zhang YM; Zhang Z Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9642-9650. PubMed ID: 31773715 [TBL] [Abstract][Full Text] [Related]
10. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity. Yeh JN; Yue Y; Chu YC; Huang CR; Yang CC; Chiang JY; Yip HK; Guo J Biomed Pharmacother; 2021 Dec; 144():112244. PubMed ID: 34601193 [TBL] [Abstract][Full Text] [Related]
11. Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy. Zhou J; Wang Z; He Y; Luo X; Zhang W; Yu L; Chen X; He X; Yuan Y; Wang X; Guo X; Tang J; Zhu M; Li D; Ding Y BMC Complement Med Ther; 2020 Jul; 20(1):203. PubMed ID: 32615967 [TBL] [Abstract][Full Text] [Related]
12. Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ. Shen S; Jiang H; Bei Y; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Wei C; Shang H; Li X Cell Physiol Biochem; 2017; 42(3):876-888. PubMed ID: 28647730 [TBL] [Abstract][Full Text] [Related]
13. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Cho E; Kim M; Ko YS; Lee HY; Song M; Kim MG; Kim HK; Cho WY; Jo SK Nephrol Dial Transplant; 2013 Nov; 28(11):2766-78. PubMed ID: 24009291 [TBL] [Abstract][Full Text] [Related]
14. Alamandine protects against renal ischaemia-reperfusion injury in rats via inhibiting oxidative stress. Zhu J; Qiu JG; Xu WT; Ma HX; Jiang K J Pharm Pharmacol; 2021 Oct; 73(11):1491-1502. PubMed ID: 34244746 [TBL] [Abstract][Full Text] [Related]
15. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome. Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663 [TBL] [Abstract][Full Text] [Related]
16. Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat. Yang CC; Chen YT; Wallace CG; Chen KH; Cheng BC; Sung PH; Li YC; Ko SF; Chang HW; Yip HK Biomed Pharmacother; 2019 Jan; 109():658-670. PubMed ID: 30404073 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of naringenin in cardiorenal syndrome. Liu Y; An W; Gao A J Surg Res; 2016 Jun; 203(2):416-23. PubMed ID: 27363651 [TBL] [Abstract][Full Text] [Related]
18. Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat. Sung PH; Chai HT; Yang CC; Chiang JY; Chen CH; Chen YL; Yip HK Biomed Pharmacother; 2022 Apr; 148():112745. PubMed ID: 35202913 [TBL] [Abstract][Full Text] [Related]
19. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction. Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541 [TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]